Navigation Links
STERRAD(R) CYCLESURE(R) Biological Indicator is now 24 Hours, Accelerating Instrument Throughput
Date:1/12/2009

IRVINE, Calif., Jan. 12 /PRNewswire/ -- Advanced Sterilization Products (ASP) is pleased to announce that its STERRAD(R) CYCLESURE(R) Biological Indicator readout time has significantly improved from a 48 hour incubation time to only 24 hours. Now, STERRAD(R) System customers can safely record biological indicator results in 50% less time, speeding up instrument throughput in the sterilization department. The product name is also changing to STERRAD(R) CYCLESURE(R) 24 Biological Indicator to reflect this time-saving improvement.

ASP successfully re-engineered the product after receiving feedback from customers requesting a faster incubation period. A faster incubation period keeps sterilization departments moving efficiently as well as limiting the need to purchase duplicate instrument inventories, which is frequently required when waiting for the results of a 48 hour or more biological indicator readout.

"ASP has been providing healthcare organizations with STERRAD(R) System technology and supplies for almost two decades," says Karen Borg, Worldwide Vice President of Marketing for ASP. "We are committed to continuous product innovation and are passionate about designing and marketing infection prevention solutions like the STERRAD(R) CYCLESURE(R) 24 Biological Indicator that not only meet our customers' needs, but often exceed them."

The STERRAD(R) CYCLESURE(R) 24 Biological Indicator can be used with all of ASP's market-leading, low-temperature hydrogen peroxide gas plasma STERRAD(R) Systems: the STERRAD(R) 100NX(TM) System, STERRAD(R) NX(TM) System, STERRAD(R) 100S System, STERRAD(R) 200 System, as well as the STERRAD(R) 50 System. The STERRAD(R) CYCLESURE(R) 24 Biological Indicator is only validated for use in STERRAD(R) Systems.

For information about STERRAD(R) System products, ASP or ASP's line of infection prevention solutions, visit www
'/>"/>

SOURCE Advanced Sterilization Products
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. ASP Launches STERRAD(R) Sterility Guide - Eliminating Paperwork and Ensuring Compliance
2. Thomson Scientific Announces BONDplus for Biological Researchers
3. Neurobiological Technologies Reports Going Concern Qualification
4. Neurobiological Technologies, Inc. Announces Receipt of Determination Letter from NASDAQ
5. Study questions assumptions about human sensitivity to biological motion
6. Neurobiological Technologies Reports $2.1 Million Quarterly Payment for Sales of Memantine
7. Neurobiological Technologies Announces Compliance With Nasdaq Listing Standards
8. Dr. Warren Wasiewski Appointed Chief Medical Officer of Neurobiological Technologies, Inc.
9. Biological markers of prostate cancer shed light on cancer burden faced by African-American men
10. Sanofi Pasteur Enters Agreement With Crucell for Next-Generation Biologicals Against Rabies
11. Biological Link Between BRCA1 and Breast Cancer Detailed

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/10/2009)...zerland, Nov. 10 ,, ... Q4 2009 Q4 2008 % Change FY 2...-- ------- -------- ------- ------- --------, ...$17,237 $20,199 (15)%, Income (Loss) from,... $264 (22)% ($1,833) $1,095 -, Di...
(Date:11/10/2009)... At a time when health is a major concern for man...uncertain, Easy Pha-max, an internationally recogn...tates. Consumers now have more options to consider...t better time to have options than now. Easy Pha-m...al products that can address many health concerns ...
(Date:11/10/2009)... It is now possible to achieve exceptionally smoo... of hard materials such as ceramics, carbide and h...he new Diamond Flex-Hone® honing tool from B... Los Angeles (PRWEB) November 10, 2009 -- Using ...ed to the ends of flexible filaments, the Diamond ...
(Date:11/9/2009)... Businesses of all sizes looking to fast-track pr...mic have a new resource at their disposal. , ...9, 2009 -- Human resource (HR) professionals looki... for the H1N1 pandemic have a new resource at thei...nter for Infectious Disease Research and Policy (C...
(Date:11/9/2009)...a, Nov. 9 /PRNewswire-Asia-FirstCall/ -- Mindray M...ng developer, manufacturer and,marketer of medical...naudited,financial results for the third quarter a...ighlights for Operations as of September 30, 2009,... million, an increase of, 3.1% over the thir...
Breaking Medicine News(10 mins):Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 2Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 3Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 4Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 5Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 6Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 7Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 8Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 9Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 10Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 11Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 12Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 13Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 14Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 15Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 16Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 17Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 18Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 19Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 20Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 21Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 22Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 23Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 24Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 25Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 26Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 27Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 28Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 29Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 30Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 31Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 32Health News:Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of $0.61 Per Share and GAAP Earnings of $0.44 Per Share 33Health News:Major Biotechnology Franchise Company Expands Rapidly Throughout the USA Amidst Mounting Health Concerns 2Health News:Diamond Honing Tool Technology: The New Standard in Surface Finishing of Hard Materials 2Health News:New H1N1 Flu Guide Offers Practical Tools and Tips for HR Professionals 2
...stitute (NHLBI) of the National Institutes of Heal...ng North American clinical trial of diabetes and c...y concerns after review of available data, althoug... to intensively lower blood glucose (sugar) below ...
... mark,its 10th anniversary of delivering identity ...industry, Sentillion, the company that created hea...r-end results. In Q4, Sentillion,added 10 new cust...ity and access management products for single,sign...
...t Increase in Sales from Same ... Greenway Medical Technologies,Inc., a leading pr...R),practice management and interoperability functi...me period in fiscal 2007,and 83 percent from the s...
...out suspected cancer-causing agents, such as deodo...sessment tool has been developed through the Cance...rra Health (SESIH) by a University of New South Wa...y such as using deodorants, artificial sweeteners ...
...es, constructed with soft lithography, should boos...re brain-behavior connections and to screen new ph... infections in humans, report 10 scientists at thr...iled in a paper appearing online ahead of regular ...
...Inc., a global,supplier of infant formulas and nut...anies to accommodate its growing number of interna... into Asia, where it formed PBM,(Guangzhou) Nutrit...007,the magazine,s annual ranking of America,s fas...
Other Medicine News:Health News:Intensive blood sugar treatment in trial of diabetes and cardiovascular disease changed 2Health News:Intensive blood sugar treatment in trial of diabetes and cardiovascular disease changed 3Health News:Intensive blood sugar treatment in trial of diabetes and cardiovascular disease changed 4Health News:Intensive blood sugar treatment in trial of diabetes and cardiovascular disease changed 5Health News:Sentillion Announces Strong Q4 Performance; Signs 10 New Customers; Sells 95,800 Licenses 2Health News:Sentillion Announces Strong Q4 Performance; Signs 10 New Customers; Sells 95,800 Licenses 3Health News:Greenway Medical Technologies Continues Record Setting Growth 2Health News:Greenway Medical Technologies Continues Record Setting Growth 3Health News:Greenway Medical Technologies Continues Record Setting Growth 4Health News:Reducing cancer panic 2Health News:New devices to boost nematode research on neurons and drugs 2Health News:New devices to boost nematode research on neurons and drugs 3
(Date:11/9/2009)...stCall/ -- Volcano Corporation (Nasdaq: VOLC ), a...of products for the diagnosis and treatment of cor...at it will be participating in the Third Annual Ca...mber 10. ,, The presentation by Scott Huenneken...in at 1 p.m., Pacific Standard Time (4 p.m., Easte...
(Date:11/9/2009)...a., Nov. 9 Hill-Rom (N...e formation of a joint venture that will focus on ... of surface replacement systems that are intended ...ements for surfaces that are technologically obsol... a global leader in patient support systems and re...
(Date:11/9/2009)...Asia-FirstCall/ -- American Oriental,Bioengineerin...a pharmaceutical,company dedicated to improving he...ercialization of a broad range of prescription and...d that it plans to release third quarter 2009,fina...the market closes. , The Company will hol...
Breaking Medicine Technology:Volcano Corporation Presentation at Canaccord Adams Conference to Be Webcast 2Hill-Rom and Encompass Group Form Joint Venture 2Hill-Rom and Encompass Group Form Joint Venture 3Hill-Rom and Encompass Group Form Joint Venture 4Hill-Rom and Encompass Group Form Joint Venture 5New Drug Could Work Against Leukemia 50663 1Sexist jokes favor the mental mechanisms that justify violence against women 50661 1Sexist jokes favor the mental mechanisms that justify violence against women 50661 2Center receives grant renewal for hypertension and vascular disease studies 50659 1Center receives grant renewal for hypertension and vascular disease studies 50659 2
...t. 31 United,Therapeutics Corporation (Nasdaq: U...., announced today that they will release the resu... inhaled formulation of treprostinil,in pulmonary ...Thursday,November 1, 2007. United Therapeutics wi... on November 1, 2007, to a full hour to accommodat...
...stal Research,Associates, LLC announced today that...(R) (EIO(R)) on CEL-SCI Corporation (Amex: CVM )....ww.crystalra.com . CEL-SCI Corporation develops i...s. Its primary product candidate is Multikine(R), ...t targets treatment-naive,newly diagnosed head and...
Other Medicine Technology:Results of TRIUMPH-1 Trial of Viveta in Pulmonary Arterial Hypertension to Be Announced Before Market Open on Thursday, November 1, 2007 2Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation 2Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation 3
Access Vitamin B12
Quantaphase II B12/RIA
Autoimmunity Screening Panel 1
...ies that have decided to change to the ELISA metho...A ANAs correlation with IFA and many user friendly...n. While no ELISA ANA currently on the market is c...A screen has been shown to be quite effective at d...
Medicine Products: